Nanotoxoids: Biomimetic nanoparticle vaccines against infections

Summary

This review describes nanotoxoids, a biomimetic vaccine strategy designed to generate immunity against infection while avoiding direct administration of active toxins. Conventional nanoparticle vaccines can protect antigens, alter their distribution, improve cellular uptake, and co-deliver adjuvants. Within that broader landscape, nanotoxoids use cell-membrane-coated nanoparticles to bind virulence proteins through their natural affinity for cellular membranes. Complexing toxins with the coated particles detains the harmful proteins while preserving native structural features that can support strong, high-avidity antibody responses. The review emphasizes that this capture process can accommodate poorly characterized mixtures of toxins, enabling rapid construction of multiantigenic formulations without first identifying and separately engineering every component. Its principal synthesis is that the membrane-coated carrier acts simultaneously as a detoxifying substrate and an antigen-presentation scaffold. This may offer advantages over chemically inactivated toxoids, particularly when antigenic breadth and preserved conformation matter. The significance is a potentially flexible route to vaccines for high-priority infectious diseases driven by secreted virulence factors. The article is a review rather than a new efficacy trial, and the abstract does not establish clinical safety, manufacturing consistency, or superiority to licensed toxoid vaccines.